School of Medicine, Hepato-Pancreato-Biliary Center, Zhongda Hospital, Southeast University, Nanjing, 210009, China.
Department of Surgical Oncology, Qin Huai Medical District of Jinling Hospital, Nanjing Medical University, Nanjing, 210009, China.
J Gastrointest Surg. 2023 Nov;27(11):2403-2413. doi: 10.1007/s11605-023-05794-7. Epub 2023 Aug 15.
The incidence of intrahepatic cholangiocarcinoma (ICC) in non-alcoholic fatty liver disease (NAFLD) is increasing gradually. The prognosis of NAFLD-ICC has not been well studied. We aim to investigate the prognosis of patients with NAFLD-ICC after curative-intent partial hepatectomy (PH).
Multi-center data from January 2003 to January 2014 were retrospectively analyzed. The prognosis of ICC was analyzed using PSM and compared with hepatitis B virus (HBV)-related ICC.
A total of 898 patients with ICC were included in this study. Of them, 199 (22.2%) were NAFLD-ICC, and 699 (77.8%) were HBV-ICC. Multivariate analysis showed that CA19-9 ≥ 37 U/mL, microvascular invasion, tumor size > 5 cm, multiple tumors, and lymph node (LN) metastasis were independent risk factors for early recurrence (ER) in ICC patients. After a 1:1 PSM, NAFLD-ICC has worse 5-year overall survival (OS) (24.0% vs. 48.9%), 5-year recurrence (80.9% vs. 55.0%), and ER (58.5% vs. 30.0%) than that of HBV-ICC (all P < 0.01). Multivariable analysis showed NAFLD was an independent risk factor for OS (hazard ratio [HR] 2.26, 95% CI 1.63-3.13, P < 0.001), tumor recurrence (HR 2.24, 95%CI 1.61-3.10, P < 0.001) and ER (HR 2.23, 95%CI 1.60-3.09, P < 0.001) in patients with ICC after PH. The sensitivity analysis indicated that NAFLD-ICC patients were more likely to experience ER.
Compared with HBV-ICC, NAFLD-ICC has a worse prognosis and was more likely to relapse early. More frequent surveillance should be considered.
非酒精性脂肪性肝病(NAFLD)相关的肝内胆管细胞癌(ICC)发病率逐渐增高。NAFLD-ICC 的预后尚未得到很好的研究。本研究旨在探讨行根治性部分肝切除术(PH)后 NAFLD-ICC 患者的预后。
回顾性分析 2003 年 1 月至 2014 年 1 月多中心数据。采用 PSM 分析 ICC 的预后,并与乙型肝炎病毒(HBV)相关 ICC 进行比较。
本研究共纳入 898 例 ICC 患者,其中 199 例(22.2%)为 NAFLD-ICC,699 例(77.8%)为 HBV-ICC。多因素分析显示,CA19-9≥37 U/ml、微血管侵犯、肿瘤直径>5cm、多发病灶和淋巴结转移是 ICC 患者早期复发(ER)的独立危险因素。经 1:1 PSM 后,NAFLD-ICC 患者的 5 年总生存率(OS)(24.0% vs. 48.9%)、5 年复发率(80.9% vs. 55.0%)和 ER(58.5% vs. 30.0%)均差于 HBV-ICC(均 P<0.01)。多变量分析显示,NAFLD 是 OS(风险比[HR]2.26,95%CI 1.63-3.13,P<0.001)、肿瘤复发(HR 2.24,95%CI 1.61-3.10,P<0.001)和 ER(HR 2.23,95%CI 1.60-3.09,P<0.001)的独立危险因素。敏感性分析表明,NAFLD-ICC 患者更易发生 ER。
与 HBV-ICC 相比,NAFLD-ICC 预后较差,更易早期复发,应考虑更频繁的监测。